Transaction · 0000875320-26-000189

Schneider Jennifer

Schneider Jennifer, DIR, reported a transaction classified as grant at VERTEX PHARMACEUTICALS INC MA involving 796.000000 shares. Reported holdings after the transaction were 796.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
VRTXVERTEX PHARMACEUTICALS INC MA
Trade date
May 01, 2026
Filing date
May 05, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded796Price unknown
Holdings after796Direct
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

VRTX price since this filing

Daily closing prices, with the filing date and available return windows
VRTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000875320-26-000189
Deferred Stock Units
Transaction date
May 01, 2026
Filed May 05, 2026, 09:29 PM · 4d delay
Shares
796 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
796 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-18 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

  2. F2

    Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursu…

  3. F3

    Fully vested.

  4. F4

    Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a…

Original filing · 0000875320-26-000189
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

VRTX